Sveinung Hole
Senior Partner @ Sarsia
Bergen, Norway
Sveinung Hole is a Senior Partner at Sarsia. He attended BI Norwegian Business School.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Sveinung Hole invests in
Stages Sveinung Hole invests in
Countries Sveinung Hole invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 2 (50%)
- Pharmaceutical 2 (50%)
Stage
- Series A 2 (50%)
- Seed 1 (25%)
- Series C 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Calluna Pharma
|
Calluna has developed a robust pipeline of selective antibodies, targeting immunological diseases. These include novel therapeutic candidates that fulfill unmet clinical needs across a spectrum of diseases. | $81.4M / Series A / Jan 23, 2024 | |
BerGenBio
|
BerGenBio is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers. | $12.5M / Series C / Feb 05, 2014 | |
|
BerGenBio
|
BerGenBio is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers. | $8.8M / Series A / Jan 09, 2012 | |
|
BerGenBio
|
BerGenBio is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers. | $1.3M / Seed / Mar 02, 2011 |
Co-Investors
About Sarsia
Sarsia is an early-stage venture capital investor that invest in science-based technology companies. It was founded in 2006 and is located in Bergen, Hordaland.
Sarsia Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Erlend Skagseth
Managing Partner
|
|||
Jon Trygve Berg
Partner
|
|||
|
Sveinung Hole
Senior Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Sveinung Hole invest in?
Sveinung Hole invests primarily in Biotechnology and Pharmaceutical startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Sveinung Hole?
Public channels for Sveinung Hole include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Sveinung Hole last invest?
The most recent investment recorded for Sveinung Hole closed in Jan 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
